<DOC>
	<DOCNO>NCT01201798</DOCNO>
	<brief_summary>The purpose study demonstrate difluprednate 0.05 % ( Durezol ) dose 4 time daily noninferior prednisolone 1 % ( Pred Forte ) dose 8 time daily treatment endogenous anterior uveitis .</brief_summary>
	<brief_title>Safety Efficacy Difluprednate 0.05 % Treatment Anterior Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis , Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Fluprednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Difluprednate</mesh_term>
	<criteria>Diagnosis endogenous anterior uveitis least 1 eye . The presence &gt; 10 cell anterior chamber least one eye , flare score &gt; 2 eye . Age 2 year old day consent . Negative urine pregnancy test Day 0 female childbearing potential least 1 year postmenopausal surgically sterilize . Other protocoldefined inclusion criterion may apply . Presence endogenous anterior uveitis diagnose &gt; 2 week prior enrollment study . Presence intermediate uveitis , posterior uveitis panuveitis either eye . Instillation topical corticosteroid NSAID study eye within 7 day instillation study drug . History glaucoma clinically significant ocular hypertension opinion Investigator involve IOP â‰¥ 21 millimeter mercury either eye . History steroidinduced elevation intraocular pressure . Any confirm suspect active viral , bacterial fungal keratoconjunctival disease either eye . History glaucoma clinically significant ocular hypertension opinion Investigator involve intraocular pressure ( IOP ) &gt; 21 mmHg either eye . Corneal abrasion ulceration either eye . Pregnancy lactation . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>